Novel Approaches to Treating Relapsed and Refractory Multiple Myeloma with a Focus on Recent Approvals of Belantamab Mafodotin and Selinexor

Joseph NS, Tai YT, Anderson KC, Lonial S

Clinical Pharmacology: Advances and Applications 2021, 13:169-180

Published Date: 18 August 2021